Gene Therapy Stock Genprex, Inc. (NASDAQ: GNPX) Makes Nasdaq Top Gainers List on News of Positive Preclinical Data on the Use of Reqorsa

Published on Oct 15, 2025

Genprex Inc. (NASDAQ: GNPX) gene therapy stock image featuring DNA helix, highlighting positive preclinical Reqorsa data and Nasdaq top gainers news

October 15, 2025- (Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a news and trading alert for Genprex, Inc. ( NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.

The stock makes the Nasdaq top gainers list today following news on the close yesterday. Genprex is trading at 0.7695, up 0.5170, gaining 204.7525% at the time of this report on volume of over 643 Million shares. The stock has a morning high of $1.10.

Genprex announced that its research collaborators will present positive preclinical data at the upcoming 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics taking place October 22-26, 2025 at the Hynes Convention Center in Boston. The collaborators will present positive preclinical data from a study of Genprex's lead drug candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), for the treatment of ALK-EML4 positive non-small cell lung cancer (NSCLC).

"We are thrilled that our collaborators have once again been selected to present positive preclinical data on the use of REQORSA and its ability to induce apoptosis in ALK positive lung cancer, a subset of NSCLC that impacts mostly young, non-smoking individuals,"

said Ryan Confer, President and Chief Executive Officer at Genprex.

"These preclinical data further validate REQORSA as a potential treatment for many types of cancer, including another subset of lung cancer, and we look forward to continuing our studies of REQORSA in combination with ALK inhibitors."

Full news

https://finance.yahoo.com/news/genprex-collaborators-present-positive-preclinical-110000679.html

Research biotech and medical device/ tech stocks at Investorideas.com

https://www.investorideas.com/BIS/

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Contact Investorideas.com

800-665-0411

Disclaimer/Disclosure: TOur site does not make recommendations for purchases or sale of stocks, services or products. This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services and prices on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp